Critical Roles of ELVOL4 and IL-33 in the Progression of Obesity-Related Cardiomyopathy via Integrated Bioinformatics Analysis

Abstract

The molecular mechanisms underlying obesity-related cardiomyopathy (ORCM) progression involve multiple signaling pathways, and the pharmacological treatment for ORCM is still limited. Thus, it is necessary to explore new targets and develop novel therapies. Microarray analysis for gene expression profiles using different bioinformatics tools has been an effective strategy for identifying novel targets for various diseases. In this study, we aimed to explore the potential genes related to ORCM using the integrated bioinformatics analysis. The GSE18897 (whole blood expression profiling of obese diet-sensitive, obese diet-resistant, and lean human subjects) and GSE47022 (regular weight C57BL/6 and diet-induced obese C57BL/6 mice) were used for bioinformatics analysis. Weighted gene co-expression network analysis (WGCNA) of GSE18897 was employed to investigate gene modules that were strongly correlated with clinical phenotypes. Gene Ontology (GO) functional enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis were performed on the co-expression genes. The expression levels of the hub genes were validated in the clinical samples. Yellow co-expression module of WGCNA in GSE18897 was found to be significantly related to the caloric restriction treatment. In addition, GO functional enrichment analysis and KEGG pathway analysis were performed on the coexpression genes in yellow co-expression module, which showed an association with oxygen transport and the porphyrins pathway. Overlap analysis of yellow co-expression module genes from GSE18897 andGSE47022 revealed six upregulated genes, and further experimental validation results showed that elongation of very-long-chain fatty acids protein 4 (ELOVL4), matrix metalloproteinase-8 (MMP-8), and interleukin-33 (IL-33) were upregulated in the peripheral blood from patients with ORCM compared to that in the controls. The bioinformatics analysis revealed that ELOVL4 expression levels are positively correlated with that of IL-33. Collectively, using WGCNA in combination with integrated bioinformatics analysis, the hub genes of ELVOL4 and IL-33 might serve as potential biomarkers for diagnosis and/or therapeutic targets for ORCM. The detailed roles of ELVOL4 and IL-33 in the pathophysiology of ORCM still require further investigation.

High-Density Lipoprotein Cholesterol in Young Nondiabetic Coronary Heart Disease Patients

“…CHD is one of the leading causes of death worldwide with a trend to be younger, despite the remarkable progress in the research of molecular and pathological mechanisms and treatment of it [17][18][19][20][21][22][23]. Identifying risk factors and adequate management is one of the corner stones of preventing CHD.…”

Decreased Spp1 Expression in Acute Myocardial Infarction after Ischemia and Reperfusion Injury

“…We obtained the GSE83472 dataset from GEO ( http://www.ncbi.nlm.nih.gov/geo/ ) [ 7 ]. The GSE83472 dataset, including 8 mouse SHAM (4 WT and 4 AKIP_TG) and 8 mouse IR (4 WT and 4 AKIP1_TG) where ischemia/reperfusion injured, was used to identify differential gene expression for mice with I/R injury.…”

Identification of hub genes and candidate herbal treatment in obesity through integrated bioinformatic analysis and reverse network pharmacology

“…Microarray analysis in systems biology is an effective tool to explore the potential genes and pathways in different diseases. It is performed by detecting tens of thousands of gene expression information using a high-throughput pattern 23 . The GEO database is the most comprehensive public functional genomics database that includes gene expression, mutation, modification, and other related information 24 .…”